IB14-03a

Main Content

The prognostic impact of levels of CXC chemokine ligands on post hematopoietic cell transplantation outcomes in patients with myelodysplastic syndromes.

Study #: IB14-03a

Study Status: Published

Presentation(s)

2016, ASH (Poster)

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.

Citation

Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon Y-T, Carlson K-S, Nazha A, Saber W.

Leukemia & Lymphoma. 2021, Jan 01: 62(1): 62(1):229-233. doi: 10.1080/10428194.2020.1817446. Epub 2020, Sep 13. PMCID:PMC7939047.

PubMed

PMID: 32924688

Abstract